Israel Englander Pfizer Inc Call Options Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $2.78 Million - $3.15 Million	-100,300 Reduced 9.47%	958,700 $27.7 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $8.38 Million - $9.82 Million	-331,700 Reduced 23.85%	1,059,000 $29.6 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $21.8 Million - $25 Million	-841,600 Reduced 37.7%	1,390,700 $38.6 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $1.22 Million - $1.58 Million	-46,600 Reduced 2.04%	2,232,300 $64.3 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $7.76 Million - $8.98 Million	214,800 Added 10.41%	2,278,900 $83.6 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $1.49 Million - $1.94 Million	-37,800 Reduced 1.8%	2,064,100 $84.2 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $26.3 Million - $34.3 Million	629,200 Added 42.72%	2,101,900 $108 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $459,480 - $560,910	-10,500 Reduced 0.71%	1,472,700 $64.4 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.